Zhou Junfeng, Lin Lin, He Cankun, Wang Ziyi, Zhan Yuping, Sun Sida, He Qingliang
Department of Gastrointestinal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Nursing Department, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Front Oncol. 2025 Apr 22;15:1566954. doi: 10.3389/fonc.2025.1566954. eCollection 2025.
This study aimed to investigate the influencing factors of postoperative intra-abdominal infection (PIAI) in gastrointestinal cancer patients by combining biomarkers in serum and drainage fluid (DF). It also intended to construct the predictive models and explore their predictive value for PIAI, offering clinical guidance.
383 patients from Institution A formed the development cohort, and 77 patients from Institution B formed the validation cohort. Independent predictors of PIAI were identified using LASSO and logistic regression analysis based on biomarkers in serum and DF, and the corresponding nomograms were constructed. The nomograms were evaluated for their performance using the calibration curve, area under the curve (AUC), decision curve analysis (DCA), and clinical impact curve (CIC).
The prevalence of PIAI was 15.9% in the development cohort and 24.7% in the validation cohort. There were 5 indicators included in the nomogram on postoperative day (POD) 1, and 4 indicators on POD 3, including DF lactate dehydrogenase and C-reactive protein. The AUC values of the models in the development and validation cohorts were 0.731 and 0.958 on POD 1, and 0.834 and 0.951 on POD 3, respectively. The calibration curve, DCA, and CIC demonstrated the favorable clinical applicability of the models.
Two nomogram models including serum and DF biomarkers on POD 1 and POD 3 were developed and validated. These models can identify patients at risk of PIAI and have promise for clinical application.
本研究旨在通过结合血清和引流液中的生物标志物,调查胃肠癌患者术后腹腔内感染(PIAI)的影响因素。本研究还旨在构建预测模型并探索其对PIAI的预测价值,为临床提供指导。
来自机构A的383例患者组成了开发队列,来自机构B的77例患者组成了验证队列。基于血清和引流液中的生物标志物,使用LASSO和逻辑回归分析确定PIAI的独立预测因素,并构建相应的列线图。使用校准曲线、曲线下面积(AUC)、决策曲线分析(DCA)和临床影响曲线(CIC)对列线图的性能进行评估。
开发队列中PIAI的患病率为15.9%,验证队列中为24.7%。术后第1天(POD 1)的列线图中有5个指标,POD 3时有4个指标,包括引流液乳酸脱氢酶和C反应蛋白。开发队列和验证队列中模型在POD 1时的AUC值分别为0.731和0.958,在POD 3时分别为0.834和0.951。校准曲线、DCA和CIC证明了模型具有良好的临床适用性。
开发并验证了两个列线图模型,包括POD 1和POD 3时的血清和引流液生物标志物。这些模型可以识别有PIAI风险的患者,具有临床应用前景。